NL-OMON55498已完成4 期
Chronotherapy with aspirin for reduction of cardiovascular disease - TImE ASPIRI
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 328
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •patients who already use low-dose aspirin for secondary prevention of
- •cardiovascular events and use a multidose drug dispensing
排除标准
- •Insufficient knowledge of the Dutch language
- •Patients currently participating in another (clinical) trial or study
研究者
相似试验
进行中（未招募）
1 期
Change the time of intake of aspirin for the reduction of cardiovascular disease.The medical condioton to be investigated is recurrent cardiovascular diseaseEUCTR2018-001328-21-NLeiden University Medical Center4,000
招募中
1 期
Aspirin to prevent cardiovascular events in patients with pneumoniaPneumonia, Myocardial infarctionCTIS2023-504553-12-01Amsterdam UMC760
终止
不适用
TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular DiseaseCardiovascular DiseasesNCT04132791Leiden University Medical Center328
已完成
不适用
Effects of aspirin for primary prevention of ASCVDs in DM type2 patientsCardiovascular Event in Type 2 diabetes patientsCardiovascular disease, Primary prevention, Aspirin, Type 2 diabetesTCTR20240328011one682
进行中（未招募）
4 期
Chronotherapy with Low-dose Aspirin for Primary PreventionType 2 DiabetesNCT00725127University of Vigo3,200